Sufentanil is the lowest effective dose for laryngeal mask insertion in children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400080027

Enrollment

Unknown

Registered

2024-01-18

Start date

2024-03-01

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia surgeries such as short body surface surgery, extremity surgery, urological surgery, and inguinal hernia repair

Interventions

Test group :Sufentanil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age 0-18 years, short body surface surgery, limb surgery, urological surgery and inguinal hernia repair and other general anesthesia surgery, ASA grade I-II

Exclusion criteria

Exclusion criteria: Patients with a history of highly reactive airway disease, a high risk of aspiration, and predictable preoperative intubation difficulties; Those who do not agree to conduct this clinical study; Those who have undergone intra-abdominal, intrathoracic, head and neck or ENT surgery; The operation time > 1h

Design outcomes

Primary

Measure	Time frame
50% minimum effective concentration;90% minimum effective concentration;success rate;complication;	—

Countries

China

Contacts

Public ContactShengfen Tu

Children's Hospital of Chongqing Medical University

519194496@qq.com+86 139 8341 6114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026